0001193125-26-099336
SEC filingRapport Therapeutics, Inc. furnished a press release as Exhibit 99.1 under Items 2.02 and 9.01 of Form 8-K on March 10, 2026, pertaining to results of operations. The filing is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act.